Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03200132
Recruitment Status : Suspended (Technical issues in data processing)
First Posted : June 27, 2017
Last Update Posted : August 21, 2018
Sponsor:
Information provided by (Responsible Party):
Maastricht University Medical Center

Brief Summary:
This study evaluates the possibility of Magnetic Resonance Imaging (MRI) based respiratory motion correction of simultaneously acquired cardiac Positron Emission Tomography (PET) images.

Condition or disease Intervention/treatment
Cardiac Imaging Diagnostic Test: Cardiac PET/MRI

Layout table for study information
Study Type : Observational
Estimated Enrollment : 15 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)
Actual Study Start Date : June 26, 2017
Estimated Primary Completion Date : December 25, 2018
Estimated Study Completion Date : December 25, 2018

Resource links provided by the National Library of Medicine



Intervention Details:
  • Diagnostic Test: Cardiac PET/MRI
    For patients undergoing 18-Fluor- fluorodeoxyglucose (18F-FDG) PET/MRI or PET/Computed Tomography (CT), additional cardiac PET/MRI scans are acquired.


Primary Outcome Measures :
  1. Target-to-background ratio (TBR) [ Time Frame: 15-20 minutes ]

Secondary Outcome Measures :
  1. Signal-to-noise ratio (SNR) [ Time Frame: 15-20 minutes ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients receiving 18F-FDG for clinical diagnostic PET/MRI or PET/CT.
Criteria

Inclusion Criteria:

  • 18F-FDG injection for clinical diagnostic PET/MRI or PET/CT

Exclusion Criteria:

  • Diet-suppressed myocardial uptake of 18F-FDG
  • General exclusion criteria for MRI (i.e. metallic implants, claustrophobia, pregnancy, etc.)
  • Not willing to be informed about incidental findings

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03200132


Locations
Layout table for location information
Netherlands
Maastricht University Hospital
Maastricht, Limburg, Netherlands, 6229HX
Sponsors and Collaborators
Maastricht University Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Joachim Wildberger, MD PhD Maastricht University Hospital
Layout table for additonal information
Responsible Party: Maastricht University Medical Center
ClinicalTrials.gov Identifier: NCT03200132    
Other Study ID Numbers: 16-4-156
First Posted: June 27, 2017    Key Record Dates
Last Update Posted: August 21, 2018
Last Verified: August 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No